The broad aim of ANZSA is to improve outcomes for sarcoma and related tumours in the Australian and New Zealand community by undertaking outstanding international basic, translational, clinical and supportive care research.

A community of giving with a courageous ambition: a fairer and more sustainable Australia. With more than 25 years catalysing positive social change, they make philanthropy easy and accessible for people from all walks of life across Australia.

Established by the Australian Government in 2006, Cancer Australia works to benefit all Australians affected by cancer and their families. ANZCHOG is supported by Cancer Australia through their Support For Cancer Clinical Trials program, as well as grants from the Medical Research Future Fund and the National Health & Medical Research Council.

Canteen supports 12-25 year-olds dealing with their own diagnosis, a close family member’s cancer or the death of a loved one. Services also extend to parents, as their wellbeing directly impacts their children’s levels of distress and anxiety.

Their mission is to raise funds for vital brain cancer research. Approximately 1,600 Australians are diagnosed with brain cancer each year and 80% will die. Brain cancer survival rates have not changed in 30 years and there is currently no cure.

Founded by parents who fought for their children, The Children’s Cancer Foundation supports families through treatment, partners with hospitals to deliver clinical excellence and builds world-class paediatric cancer clinical research.

This US-based clinical trials group is the world’s largest organisation devoted exclusively to childhood and adolescent cancer research. COG unites more than 9000 experts in childhood cancer at more than 200 leading children’s hospitals, universities and cancer centres across North America, Australia, New Zealand and Europe in the fight against childhood cancer.

On a mission to #CONQUERNF, the Foundation provides a pathway from fear to hope by investing in promising research, advocating for better resources and empowering individuals and families with knowledge and support at every stage of their journey.

The peak national body representing multidisciplinary health professionals whose work encompasses cancer control and care. COSA members include doctors, nurses, scientists and allied health professionals involved in the clinical care of cancer patients.

The COllaborative Network for NEuro-oncology Clinical Trials (CONNECT) seeks to improve outcomes by conducting nimble, scientifically rational, international trials to demonstrate the safety and feasibility of incorporating novel agents and therapeutic modalities into the most effective current regimens for children with newly-diagnosed high-risk brain tumours.

COGNO was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large scale multi-centred neuro-oncology trials. COGNO’s main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours.

The leading organisation for brain cancer research, advocacy and awareness in Australia. They forge global collaborations, fund innovative research and bring world-class clinical trials to Australia to give patients access to new treatments faster.

SIOP Europe now encompasses a range of European Trials Groups targeting specific paediatric tumours, including:
International BFM (I-BFM) study group: leukaemia and lymphoma.
EuroEwing Consortium: Ewing’s Tumour
European Hodgkin’s Consortium/ EuroNET-PHL: Hodgkins Lymphoma
SIOP Europe Neuroblastoma Group (SIOPEN): Neuroblasma
European Paediatric Soft Tissue Sarcoma Study Group (EpSSSG): Soft tissue sarcomas

This Foundation is supported by participants of Australia’s financial community, receiving both corporate and individual donations to fund research programs and projects designed to improve the health, welfare and well-being of Australia’s children.

Established to raise much-needed funds for research into Neurofibromatosis. The Flicker of Hope Foundation has raised over $600,000 in just two years, with 100% of funds used to support essential NF research.

The largest biomedical research institute in Germany and a member of the Helmholtz Association of National Research Centres. DKFZ has more than 90 divisions and research groups, and more than 3000 employees, of which more than 1200 are scientists. Together, they’re investigating the mechanisms of cancer, identifying cancer risk factors and trying to find strategies to prevent people from getting cancer. DFKZ is developing novel approaches to make tumour diagnosis more precise and treatment of cancer patients more successful.

An accounting, business advisory and financial planning firm providing quality personal services to the SME and family business sector. They provide high quality, practical advice assisting clients in running their businesses and enhancing their wealth.

The HMPPM is a cross-institutional discovery and translational research program for paediatric cancers, led by Hudson Institute scientists and funded by the Children’s Cancer Foundation. The program has developed one of the largest repositories of childhood cancer models in the world and utilises state-of-the art functional genomic and multi-dimensional profiling technologies to develop the next generation of precision oncology therapeutic targets for paediatric tumours of greatest unmet medical need.

Created in 2003 as a non-profit organisation under French law, ITCC gathers 54 European Paediatric Oncology Departments with expertise in conducting early phase trials in children and adolescents, and 22 European research laboratories. The aim of ITCC is to develop novel therapies for the treatment of paediatric and adolescent cancers in cooperation with regulatory bodies, pharmaceutical enterprises, parents and patients.

Established after Isabella and Marcus lost their lives to Diffuse Intrinsic Pontine Glioma (DIPG). Their families pursue improving quality of life for children diagnosed with brainstem tumours and are working to find a cure.

Established by the Muldoon family in memory of Lachie Muldoon. They raise funds to support research in personalised medicine and immunotherapy as the way forward to finding a cure for brain cancer patients.

Shaping the health care of children by investing in excellent research so that all children can live healthy and productive lives. Their mission is to have a voice on state, national and international platforms so research directly improves children’s health.

A modern philanthropic organisation taking on tough, persistent issues with the potential to drive massive change. One of Asia’s largest philanthropies with AUD $2 billion committed to global initiatives, including reducing cancer and accelerating breakthrough therapies.

A volunteer-led organisation working to support patients and families affected by cancer. Over 28 years they have raised over $24 million to fund patient and family support, medical equipment, clinical care, research and trials.

The Pacific Pediatric Neuro-Oncology Consortium (PNOC) is a network of 18 children’s hospitals that conduct clinical trials of new therapies for children with brain tumours. PNOC’s goal is to improve outcomes by translating the latest findings in cancer biology into better treatments for these children.

A boutique law firm offering services in the corporate and commercial area. Their experienced partners provide practical advice on contractual and commercial law matters to clients ranging from multinational public companies to privately owned concerns.

With a single purpose of funding blood cancer research, the Snowdome Foundation accelerates next-generation treatments to help Australians with blood cancer live longer, better lives. They are dedicated to making hope real.